World Journal of
Pharmaceutical and Life Sciences

REVIEW ON CARDIOVASCULAR RISK IN PATIENTS WITH HEMOPHILIA

Dr. Manish Kumar*, Dr. Rajesh Kumar Sharma, Dr. Akhilesh Patel, Shivam Singh and Himanshu Kumar

ABSTRACT

Beyond its core signs, hemophilia—a hereditary bleeding illness defined by clotting factor shortage or dysfunction—presents special problems. There appears to be a correlation between hemophilia and cardiovascular risk, which calls for a thorough examination. In order to clarify the relationship between hemophilia and cardiovascular health, this study summarizes recent research and looks at probable causes, risk factors, and clinical consequences. Important discoveries demonstrate the complex relationship between cardiovascular risk and hemophilia patients, including comorbidities, inflammation, coagulation irregularities, and physical inactivity. Moreover, this study emphasizes the significance of customized treatment approaches and interdisciplinary care to reduce cardiovascular risk and improve outcomes in this susceptible group. This study seeks to enlighten physicians, researchers, and policymakers on the cardiovascular implications of hemophilia. This will facilitate the development of tailored therapies and improve the overall health outcomes of individuals with hemophilia.

[Full Text Article]   [Download Certificate]